Pancreatic Cancer Research

ResearcherCarolinas Healthcare SystemNo recent work listed

John B. Martinie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2677-9134; OpenAlex author ID A5025603719. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 3 papers · 2022: none · 2023: 1 paper

Papers 10

  1. Robotic versus laparoscopic distal pancreatectomy for pancreatic adenocarcinoma in obese patients. Co-author DOI 10.1002/rcs.2596↗
  2. The treatment sequence may matter in patients undergoing pancreatoduodenectomy for early stage pancreatic cancer in the era of modern chemotherapy. Co-author DOI 10.1016/j.amjsurg.2020.10.030↗
  3. Oncologic Outcomes of Robotic Left Pancreatectomy for Pancreatic Adenocarcinoma: A Single-Center Comparison to Laparoscopic Resection. Last author DOI 10.1177/0003134820949524↗
  4. Pure and Hybrid Deep Learning Models can Predict Pathologic Tumor Response to Neoadjuvant Therapy in Pancreatic Adenocarcinoma: A Pilot Study. Co-author DOI 10.1177/0003134820982557↗
  5. Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database. Co-author DOI 10.1089/pancan.2020.0011↗
  6. Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National… Co-author DOI 10.3747/co.26.4066↗
  7. Robotic pancreaticoduodenectomy for pancreatic adenocarcinoma: role in 2014 and beyond. Last author DOI 10.3978/j.issn.2078-6891.2015.027↗
  8. The impact of regionalization of pancreaticoduodenectomy for pancreatic Cancer in North Carolina since 2004. Co-author DOI 10.1177/000313481408000619↗
  9. The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer. Co-author DOI 10.1002/jso.23316↗
  10. Discovery of putative pancreatic cancer biomarkers using subcellular proteomics. Co-author DOI 10.1016/j.jprot.2010.08.006↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dionisios V. Vrochides · 7 shared papers, 2015–2023 · strength 0.80
  2. David A. Iannitti · 9 shared papers, 2011–2021 · strength 0.77
  3. Erin H. Baker · 6 shared papers, 2015–2021 · strength 0.67
  4. Lee Mayer Ocuin · 4 shared papers, 2020–2021 · strength 0.50
  5. Michael David Watson · 4 shared papers, 2020–2021 · strength 0.50
  6. Maria R. Baimas‐George · 2 shared papers, 2021 · strength 0.26
  7. Jimmy J. Hwang · 1 shared paper, 2021 · strength 0.13
  8. Laleh Golkar Melstrom · 1 shared paper, 2023 · strength 0.13
  9. Fabio Ausania · 1 shared paper, 2023 · strength 0.13
  10. Steven Alan White · 1 shared paper, 2023 · strength 0.13
  11. Riccardo Memeo · 1 shared paper, 2023 · strength 0.13
  12. Yuman Fong · 1 shared paper, 2023 · strength 0.13
  13. Dianrong Xiu · 1 shared paper, 2023 · strength 0.13
  14. Carolina González Abós · 1 shared paper, 2023 · strength 0.13
  15. Gregorio Di Franco · 1 shared paper, 2023 · strength 0.13
  16. Pier Cristoforo Giulianotti · 1 shared paper, 2023 · strength 0.13
  17. Luca Morelli · 1 shared paper, 2023 · strength 0.13
  18. Jennifer Lee Miller-Ocuin · 1 shared paper, 2020 · strength 0.11
  19. Michael J. Passeri · 1 shared paper, 2019 · strength 0.11
  20. Ryan Z. Swan · 2 shared papers, 2014–2015 · strength 0.10
  21. Dahlia M. Besmer · 1 shared paper, 2013 · strength 0.03
  22. Andrea M. Murphy · 1 shared paper, 2013 · strength 0.03
  23. Jennifer M. Curry · 1 shared paper, 2013 · strength 0.03
  24. Pinku Mukherjee · 1 shared paper, 2013 · strength 0.03
  25. Valery Z. Grdzelishvili · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.